| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |